Top Biotech Stocks to Watch: Expert Analysisby Lilu Anderson 13.08.2024Discover promising biotech stocks with expert insights on market trends and innovative drugmakers worth your investment.
Recursion Merges with Exscientia to Accelerate Drug Discoveryby Lilu Anderson 13.08.2024Recursion Pharmaceuticals merges with Exscientia to revolutionize drug discovery, bringing new treatments to market more quickly.
Natera Inc. Reports Strong Revenue Growth in Q2 2024by Mark Eisenberg 10.08.2024Natera Inc. sees a 58% revenue surge in Q2 2024, driven by high test volumes and ASP growth, raising guidance ...
23andMe Reports Q1 Revenue Drop, Narrows Lossesby Mark Eisenberg 10.08.202423andMe's Q1 revenue declines by 34% but narrows losses. Focus on AI and genetic studies drives future growth.
Bruker Reports 17.4% Revenue Growth in Q2 2024by Mark Eisenberg 10.08.2024Bruker sees strong growth in Q2 2024, with strategic acquisitions boosting revenues despite challenges in biopharma and Chinese markets.
Southern Miss Fuels Biotech Growth in Mississippiby Lilu Anderson 09.08.2024Southern Miss advances biomaterials research for immune disease treatment with a $2.5M collaboration, boosting Mississippi's biotech.
Biotech Stocks to Buy in Market Downturnby Lilu Anderson 08.08.2024Explore top biotech stocks poised for growth amid market challenges. Learn about innovations and opportunities in gene therapy.
Aditxt (ADTX) Stock Surges 49% on Clinical Trial Proposalby Lilu Anderson 08.08.2024Aditxt (ADTX) stock is soaring after a major update on a clinical trial for early ovarian cancer detection, driving heavy ...
Rhythm Pharmaceuticals Reports Strong Q2 Results, Driven by IMCIVREEby Mark Eisenberg 07.08.2024Rhythm Pharmaceuticals sees robust Q2 2024 results with $29.1M revenues due to IMCIVREE's success in treating Bardet-Biedl syndrome.
PAHO and IDB Launch AI Readiness Toolkit for Public Healthby Lilu Anderson 07.08.2024Discover how PAHO and IDB are helping countries integrate AI into public health with their new readiness assessment toolkit.